Clinical Trial Update: Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of montelukast and montelukast sodium (Singulair) for asthma and allergic rhinitis has been completed. The update summa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Montelukast (Montelukast)
• SINGULAIR (montelukast)

Snippet

Sponsor: PharmaKing | Conditions: Asthma and Allergic Rhinitis | Phase 1 | Status: COMPLETED